05
Sep
Andrew Kathindi As the debate rages on, the Center for Disease Control (CDC) has dismissed claims that Remdesivir, a drug being used to treat COVID-19 patients, is being used in Namibia on a clinical trial basis. This comes as the drug, which has been approved only on an emergency basis by the American Food and Drug Administration (FDA) has divided opinions over its safety and the intentions of its circulation in the country, with some doctors claiming that the drug is under clinical trial to see if it can officially be registered for the treatment of COVID-19. “The FDA approval…